Critical evaluation of cancer risks in glomerular disease.

Thet Z, Lam AK, Ranganathan D, Aung SY, Han T, Khoo TK.

Open source

DOI: 10.1016/j.tranon.2022.101376
Published: 2022-02-24
Container: Transl Oncol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.tranon.2022.101376,
  title = {Critical evaluation of cancer risks in glomerular disease.},
  author = {Thet Z and  Lam AK and  Ranganathan D and  Aung SY and  Han T and  Khoo TK.},
  year = {2022},
  journal = {Transl Oncol},
  doi = {10.1016/j.tranon.2022.101376},
  url = {https://doi.org/10.1016/j.tranon.2022.101376}
}

RIS

TY  - JOUR
TI  - Critical evaluation of cancer risks in glomerular disease.
AU  - Thet Z
AU  -  Lam AK
AU  -  Ranganathan D
AU  -  Aung SY
AU  -  Han T
AU  -  Khoo TK.
PY  - 2022
JO  - Transl Oncol
DO  - 10.1016/j.tranon.2022.101376
UR  - https://doi.org/10.1016/j.tranon.2022.101376
ER  -

APA

Z, T., AK, L., D, R., SY, A., T, H., & TK., K. (2022). Critical evaluation of cancer risks in glomerular disease.. Transl Oncol. https://doi.org/10.1016/j.tranon.2022.101376

Source records

europe-pmc · retrieved 2026-09-27T14:14:50.631Z
doaj · retrieved 2026-09-27T14:14:50.611Z